Ignite Creation Date:
2025-12-25 @ 5:09 AM
Ignite Modification Date:
2025-12-26 @ 4:13 AM
Study NCT ID:
NCT05645627
Status:
COMPLETED
Last Update Posted:
2024-10-29
First Post:
2022-12-01
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study to Evaluate IBI112 in the Treatment of Psoriasis With Moderate to Severe Plaque Psoriasis
Sponsor:
Innovent Biologics (Suzhou) Co. Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-02-10
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-08-01
Completion Date Type:
ACTUAL
First Submit Date:
2022-12-01
First Submit QC Date:
None
Study First Post Date:
2022-12-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-28
Last Update Post Date:
2024-10-29
Last Update Post Date Type:
ACTUAL